Roche, Dualitas team up to find bispecific drugs for immune diseases

PartnershipPositive

AI Analysis

Summary

Roche and Dualitas have entered into a research partnership worth up to $1 billion to discover bispecific antibody drugs for immune diseases, with Dualitas screening over 300,000 possible bispecific combinations.

Importance:6/10

Sentiment:

0.60

partnershipbispecific antibodiesimmunologydrug discoverycollaboration

Related Companies

$RHHBY

Read the original article

Published by BioPharma Dive on September 17, 2026 10:00 AM

Read Original